Vaxfab Enterprises board approved allotment of 13,28,861 equity shares at ₹21.02 each upon warrant conversion.
The preferential allotment increased paid-up equity capital to ₹22.20 crore comprising 2.22 crore shares.
Three LLP investors converted warrants, paying ₹15.765 per warrant for conversion into equity shares.
The new shares will rank pari-passu with existing equity shares of the company.